FREDERIC MOLL - 08 Feb 2024 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frederic H. Moll
Issuer symbol
SWAV
Transactions as of
08 Feb 2024
Transactions value $
$50,000
Form type
4
Filing time
09 Feb 2024, 20:07:36 UTC
Previous filing
08 Dec 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $50K +82K +30.87% $0.61* 348K 08 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -82K -100% $0.00* 0 08 Feb 2024 Common Stock 82K $0.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total reported in Column 5 of Table I includes 33,960 shares of the issuer's common stock previously held by MBL-2 Holdings LLC (the "LLC"), which were previously distributed, for no consideration, to the reporting person's direct ownership in a transaction exempt from reporting pursuant to Rule 16a-13. The reporting person is the sole managing member of the LLC.
F2 Fully vested.